Devin Abrahami, PhD

Research Fellow
Brigham and Women's Hospital, Harvard Medical School
Boston, Massachusetts, United States

Devin Abrahami is a postdoctoral fellow in the Division of Pharamcoepidemiology and Pharmacoeconomics at the Brigham and Women's Hospital and Harvard Medical School. She completed her PhD at McGill University in the Department of Epidemiology, Biostatistics and Occupational Health with a specialization in Pharmacoepidemiology. She has an MSc in Experimental Medicine (McGill University) and a BSc in Chemistry (Western University). Under the supervision of Dr. Elisabetta Patorno, she is primarily focused on cardiometabolic pharmacoepidemiology.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Contemporary Trends in the Utilization of Second-line Pharmacological Therapies for Type 2 Diabetes in the United States

  Friday, August 26, 2022
  5:30 PM – 5:45 PM CEST

• Trends and Prescription Patterns of Medications for Secondary Stroke Prevention in Denmark, 2013—2018

  Friday, August 26, 2022
  6:15 PM – 6:30 PM CEST

• Sodium-glucose Co-transporter 2 Inhibitors and the Risk of Early Bladder Cancer Events

  Saturday, August 27, 2022
  2:00 PM – 2:15 PM CEST

• Cardiovascular Effectiveness of SGLT2 Inhibitors: Head-to-head Comparisons

  Sunday, August 28, 2022
  9:15 AM – 9:30 AM CEST

• The Comparative Safety of Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis

  Sunday, August 28, 2022
  2:00 PM – 2:15 PM CEST